Cogstate Ltd CGS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$1.25
- Day Range
- A$1.23–1.32
- 52-Week Range
- A$1.13–1.87
- Bid/Ask
- A$1.26 / A$1.24
- Market Cap
- A$222.85 Mil
- Volume/Avg
- 64,005 / 103,822
Key Statistics
- Price/Earnings (Normalized)
- 28.83
- Price/Sales
- 3.90
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.95%
Company Profile
Cogstate Ltd is a cognitive science company. The principal activity of the company is the sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis, and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 380
- Website
- https://www.cogstate.com
Comparables
Valuation
|
Metric
|
CGS
|
301333
|
688253
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.83 | 40.88 | 52.01 |
Price/Book Value | 4.00 | 2.92 | 2.64 |
Price/Sales | 3.90 | 7.13 | 10.38 |
Price/Cash Flow | 330.32 | 25.09 | 34.10 |
Price/Earnings
CGS
301333
688253
Financial Strength
|
Metric
|
CGS
|
301333
|
688253
|
|---|---|---|---|
Quick Ratio | 2.87 | — | 18.25 |
Current Ratio | 3.24 | — | 18.83 |
Interest Coverage | 74.18 | — | 349.72 |
Quick Ratio
CGS
301333
688253
Profitability
|
Metric
|
CGS
|
301333
|
688253
|
|---|---|---|---|
Return on Assets (Normalized) | 12.25% | — | 4.47% |
Return on Equity (Normalized) | 18.04% | — | 4.81% |
Return on Invested Capital (Normalized) | 17.02% | — | 4.51% |
Return on Assets
CGS
301333
688253
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Mswzh | $38.9 Bil | |
VEEV
| Veeva Systems Inc Class A | Rmzyrvfks | Pgb | $32.1 Bil | |
SOLV
| Solventum Corp | — | Byysm | $10.7 Bil | |
MTHRF
| M3 Inc | — | Fdstmtb | $8.3 Bil | |
MTHRY
| M3 Inc ADR | — | Pmwfpw | $8.3 Bil | |
HQY
| HealthEquity Inc | — | Tflct | $6.9 Bil | |
PMCUF
| Pro Medicus Ltd | — | Rjxfft | $6.7 Bil | |
RCM
| R1 RCM Inc | — | Lfzk | $5.1 Bil | |
DOCS
| Doximity Inc Class A | — | Wtgrdzc | $4.7 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Clwh | $3.5 Bil |